Crystal Structures of Lipoglycopeptide Antibiotic Deacetylases: Implications for the Biosynthesis of A40926 and Teicoplanin

Chemistry and Biology

Volumn 15, Issue 6, 2008, Pages 533-545

  Zou, Yaozhong ^a   Brunzelle, Joseph S ^b   Nair, Satish K ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

CHEMBIO; MICROBIO; PROTEINS

Indexed keywords

A 40926; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; DRUG DERIVATIVE; ENZYME INHIBITOR; HYDROLASE; PRIMER DNA; TEICOPLANIN; ZINC;

ACTINOMYCETALES; AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; BIOSYNTHESIS; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY; X RAY CRYSTALLOGRAPHY;

ACTINOMYCETALES; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; BINDING SITES; CATALYSIS; CRYSTALLOGRAPHY, X-RAY; DNA PRIMERS; ENZYME INHIBITORS; HYDROLASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID; TEICOPLANIN; ZINC;

POSIBACTERIA;

EID: 44949250886     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2008.05.009     Document Type: Article

References (60)

1. Allen N.E., and Nicas T.I. Mechanism of action of oritavancin and related glycopeptide antibiotics. FEMS Microbiol. Rev. 26 (2003) 511-532
2. Anstead G.M., and Owens A.D. Recent advances in the treatment of infections due to resistant Staphylococcus aureus. Curr. Opin. Infect. Dis. 17 (2004) 549-555
3. Anstead G.M., Quinones-Nazario G., and Lewis II J.S. Treatment of infections caused by resistant Staphylococcus aureus. Methods Mol. Biol. 391 (2007) 227-258
4. Beauregard D.A., Williams D.H., Gwynn M.N., and Knowles D.J. Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics. Antimicrob. Agents Chemother. 39 (1995) 781-785
5. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., and Bourne P.E. The Protein Data Bank. Nucleic Acids Res. 28 (2000) 235-242
6. Blair D.E., Schuttelkopf A.W., MacRae J.I., and van Aalten D.M. Structure and metal-dependent mechanism of peptidoglycan deacetylase, a streptococcal virulence factor. Proc. Natl. Acad. Sci. USA 102 (2005) 15429-15434
7. Bricogne G., Vonrhein C., Flensburg C., Schiltz M., and Paciorek W. Generation, representation and flow of phase information in structure determination: recent developments in and around SHARP 2.0. Acta Crystallogr. D Biol. Crystallogr. 59 (2003) 2023-2030
8. Christianson D.W. Structural biology of zinc. Adv. Protein Chem. 42 (1991) 281-355
9. Coggins B.E., McClerren A.L., Jiang L., Li X., Rudolph J., Hindsgaul O., Raetz C.R., and Zhou P. Refined solution structure of the LpxC-TU-514 complex and pKa analysis of an active site histidine: insights into the mechanism and inhibitor design. Biochemistry 44 (2005) 1114-1126
10. Cooper M.A., and Williams D.H. Binding of glycopeptide antibiotics to a model of a vancomycin-resistant bacterium. Chem. Biol. 6 (1999) 891-899
11. Cunha B.A. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus. Med. Clin. North Am. 90 (2006) 1165-1182
12. Djinovic K., Gatti G., Coda A., Antolini L., Pelosi G., Desideri A., Falconi M., Marmocchi F., Rotilio G., and Bolognesi M. Crystal structure of yeast Cu,Zn superoxide dismutase. Crystallographic refinement at 2.5 Å resolution. J. Mol. Biol. 225 (1992) 791-809
13. Donadio S., Sosio M., Stegmann E., Weber T., and Wohlleben W. Comparative analysis and insights into the evolution of gene clusters for glycopeptide antibiotic biosynthesis. Mol. Genet. Genomics 274 (2005) 40-50
14. Dong S.D., Oberthur M., Losey H.C., Anderson J.W., Eggert U.S., Peczuh M.W., Walsh C.T., and Kahne D. The structural basis for induction of VanB resistance. J. Am. Chem. Soc. 124 (2002) 9064-9065
15. Gennadios H.A., Whittington D.A., Li X., Fierke C.A., and Christianson D.W. Mechanistic inferences from the binding of ligands to LpxC, a metal-dependent deacetylase. Biochemistry 45 (2006) 7940-7948
16. Goldstein B.P., Selva E., Gastaldo L., Berti M., Pallanza R., Ripamonti F., Ferrari P., Denaro M., Arioli V., and Cassani G. A40926, a new glycopeptide antibiotic with anti-Neisseria activity. Antimicrob. Agents Chemother. 31 (1987) 1961-1966
17. Gomez-Ortiz M., Gomis-Ruth F.X., Huber R., and Aviles F.X. Inhibition of carboxypeptidase A by excess zinc: analysis of the structural determinants by X-ray crystallography. FEBS Lett. 400 (1997) 336-340
18. Hermoso J.A., Lagartera L., Gonzalez A., Stelter M., Garcia P., Matinez-Ripoll M., Garcia J.L., and Menendez M. Insights into pneumococcal pathogenesis from the crystal structure of the modular teichoic acid phosphorylcholine esterase Pce. Nat. Struct. Mol. Biol. 12 (2005) 533-538
19. Hernick M., Gennadios H.A., Whittington D.A., Rusche K.M., Christianson D.W., and Fierke C.A. UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase functions through a general acid-base catalyst pair mechanism. J. Biol. Chem. 280 (2005) 16969-16978
20. Higgins D.L., Chang R., Debabov D.V., Leung J., Wu T., Krause K.M., Sandvik E., Hubbard J.M., Kaniga K., Schmidt Jr. D.E., et al. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 49 (2005) 1127-1134
21. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., and Tenover F.C. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40 (1997) 135-136
22. Ho J.Y., Huang Y.T., Wu C.J., Li Y.S., Tsai M.D., and Li T.L. Glycopeptide biosynthesis: Dbv21/Orf2 from dbv/tcp gene clusters are N-Ac-Glm teicoplanin pseudoaglycone deacetylases and Orf15 from cep gene cluster is a Glc-1-P thymidyltransferase. J. Am. Chem. Soc. 128 (2006) 13694-13695
23. Holland D.R., Hausrath A.C., Juers D., and Matthews B.W. Structural analysis of zinc substitutions in the active site of thermolysin. Protein Sci. 4 (1995) 1955-1965
24. Holm L., and Sander C. Dali: a network tool for protein structure comparison. Trends Biochem. Sci. 20 (1995) 478-480
25. Kahne D., Leimkuhler C., Lu W., and Walsh C. Glycopeptide and lipoglycopeptide antibiotics. Chem. Rev. 105 (2005) 425-448
26. Kleywegt G.J., and Brunger A.T. Checking your imagination: applications of the free R value. Structure 4 (1996) 897-904
27. Kruger R.G., Lu W., Oberthur M., Tao J., Kahne D., and Walsh C.T. Tailoring of glycopeptide scaffolds by the acyltransferases from the teicoplanin and A-40,926 biosynthetic operons. Chem. Biol. 12 (2005) 131-140
28. Laskowski R.A., Rullmannn J.A., MacArthur M.W., Kaptein R., and Thornton J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8 (1996) 477-486
29. Li T.L., Huang F., Haydock S.F., Mironenko T., Leadlay P.F., and Spencer J.B. Biosynthetic gene cluster of the glycopeptide antibiotic teicoplanin: characterization of two glycosyltransferases and the key acyltransferase. Chem. Biol. 11 (2004) 107-119
30. Liu J., and Mushegian A. Three monophyletic superfamilies account for the majority of the known glycosyltransferases. Protein Sci. 12 (2003) 1418-1431
31. Malabarba A., Strazzolini P., Depaoli A., Landi M., Berti M., and Cavalleri B. Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VI. Chemical degradation: physico-chemical and biological properties of acid hydrolysis products. J. Antibiot. (Tokyo) 37 (1984) 988-999
32. Martinez J.L., Baquero F., and Andersson D.I. Predicting antibiotic resistance. Nat. Rev. Microbiol. 5 (2007) 958-965
33. Maynes J.T., Garen C., Cherney M.M., Newton G., Arad D., Av-Gay Y., Fahey R.C., and James M.N. The crystal structure of 1-D-myo-inosityl 2-acetamido-2-deoxy-alpha-D-glucopyranoside deacetylase (MshB) from Mycobacterium tuberculosis reveals a zinc hydrolase with a lactate dehydrogenase fold. J. Biol. Chem. 278 (2003) 47166-47170
34. McCarthy A.A., Peterson N.A., Knijff R., and Baker E.N. Crystal structure of MshB from Mycobacterium tuberculosis, a deacetylase involved in mycothiol biosynthesis. J. Mol. Biol. 335 (2004) 1131-1141
35. McClerren A.L., Zhou P., Guan Z., Raetz C.R., and Rudolph J. Kinetic analysis of the zinc-dependent deacetylase in the lipid A biosynthetic pathway. Biochemistry 44 (2005) 1106-1113
36. McCoy A.J. Solving structures of protein complexes by molecular replacement with Phaser. Acta Crystallogr. D Biol. Crystallogr. 63 (2007) 32-41
37. McRee D.E. XtalView/Xfit-a versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125 (1999) 156-165
38. Moellering Jr. R.C. Vancomycin: a 50-year reassessment. Clin. Infect. Dis. 42 Suppl 1 (2006) S3-S4
39. Murray B.E. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342 (2000) 710-721
40. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53 (1997) 240-255
41. Murshudov G.N., Vagin A.A., Lebedev A., Wilson K.S., and Dodson E.J. Efficient anisotropic refinement of macromolecular structures using FFT. Acta Crystallogr. D Biol. Crystallogr. 55 (1999) 247-255
42. Newton G.L., Av-Gay Y., and Fahey R.C. N-Acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside deacetylase (MshB) is a key enzyme in mycothiol biosynthesis. J. Bacteriol. 182 (2000) 6958-6963
43. Newton G.L., Ko M., Ta P., Av-Gay Y., and Fahey R.C. Purification and characterization of Mycobacterium tuberculosis 1D-myo-inosityl-2-acetamido-2-deoxy-alpha-D-glucopyranoside deacetylase, MshB, a mycothiol biosynthetic enzyme. Protein Expr. Purif. 47 (2006) 542-550
44. Otwinowski Z., Borek D., Majewski W., and Minor W. Multiparametric scaling of diffraction intensities. Acta Crystallogr. A 59 (2003) 228-234
45. Pelzer S., Sussmuth R., Heckmann D., Recktenwald J., Huber P., Jung G., and Wohlleben W. Identification and analysis of the balhimycin biosynthetic gene cluster and its use for manipulating glycopeptide biosynthesis in Amycolatopsis mediterranei DSM5908. Antimicrob. Agents Chemother. 43 (1999) 1565-1573
46. Perrakis A., Sixma T.K., Wilson K.S., and Lamzin V.S. wARP: improvement and extension of crystallographic phases by weighted averaging of multiple-refined dummy atomic models. Acta Crystallogr. D Biol. Crystallogr. 53 (1997) 448-455
47. Rawat M., Kovacevic S., Billman-Jacobe H., and Av-Gay Y. Inactivation of mshB, a key gene in the mycothiol biosynthesis pathway in Mycobacterium smegmatis. Microbiology 149 (2003) 1341-1349
48. Scheinfeld N. Dalbavancin: a review. Drugs Today (Barc) 43 (2007) 305-316
49. Sieradzki K., Roberts R.B., Haber S.W., and Tomasz A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. 340 (1999) 517-523
50. Sosio M., Stinchi S., Beltrametti F., Lazzarini A., and Donadio S. The gene cluster for the biosynthesis of the glycopeptide antibiotic A40926 by Nonomuraea species. Chem. Biol. 10 (2003) 541-549
51. Sosio M., Kloosterman H., Bianchi A., de Vreugd P., Dijkhuizen L., and Donadio S. Organization of the teicoplanin gene cluster in Actinoplanes teichomyceticus. Microbiology 150 (2004) 95-102
52. Spencer C.M., and Bryson H.M. Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of Gram-positive infections. Pharmacoeconomics 7 (1995) 357-374
53. Truman A.W., Robinson L., and Spencer J.B. Identification of a deacetylase involved in the maturation of teicoplanin. ChemBioChem 7 (2006) 1670-1675
54. Truman A.W., Huang F., Llewellyn N.M., and Spencer J.B. Characterization of the enzyme BtrD from Bacillus circulans and revision of its functional assignment in the biosynthesis of butirosin. Angew. Chem. Int. Ed. Engl. 46 (2007) 1462-1464
55. Van Bambeke F. Glycopeptides and glycodepsipeptides in clinical development: a comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacy. Curr. Opin. Investig. Drugs 7 (2006) 740-749
56. van Duyne G.D., Standaert R.F., Karplus P.A., Schreiber S.L., and Clardy J. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J. Mol. Biol. 229 (1993) 105-124
57. van Wageningen A.M., Kirkpatrick P.N., Williams D.H., Harris B.R., Kershaw J.K., Lennard N.J., Jones M., Jones S.J., and Solenberg P.J. Sequencing and analysis of genes involved in the biosynthesis of a vancomycin group antibiotic. Chem. Biol. 5 (1998) 155-162
58. Whittington D.A., Rusche K.M., Shin H., Fierke C.A., and Christianson D.W. Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis. Proc. Natl. Acad. Sci. USA 100 (2003) 8146-8150
59. Wiliams D.H., and Bardsley B. The vancomycin group of antibiotics and the fight against resistant bacteria. Angew. Chem. Int. Ed. Engl. 38 (1999) 1172-1193
60. Zinner S.H. Antibiotic use: present and future. New Microbiol. 30 (2007) 321-325